fda bpc-157 FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the compounding list now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled them Repost @peptides with @use.repost ・・・

Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA Advisers Vote to Ease Restrictions on BPC 157, TB 500, and Other Novel Peptides Glitchwire FDA panel votes to place popular peptide BPC 157 on compounding list Reuters FDA commitee votes 8 6 to make BPC 157 legal. What the FDA briefing report said about the evidence. Empirical Health

SKU: 62855030151 · From vanierexcavation.com